Journal of Electrocardiology
Volume 43, Issue 5 , Pages 408-414, September 2010

Type 1 electrocardiographic burden is increased in symptomatic patients with Brugada syndrome

  • Fabrice Extramiana, MD, PhD

      Affiliations

    • Lariboisière Hospital APHP, University Paris Diderot, INSERM U942, Paris, France
    • Corresponding Author InformationCorresponding author. Cardiology Department, Lariboisière University Hospital, 2, rue Ambroise Paré - 75010 Paris, France.
  • ,
  • Pierre Maison-Blanche, MD

      Affiliations

    • Lariboisière Hospital APHP, University Paris Diderot, INSERM U942, Paris, France
  • ,
  • Fabio Badilini, PhD

      Affiliations

    • AMPS LLC, New York, NY, USA
  • ,
  • Anne Messali, MD

      Affiliations

    • Lariboisière Hospital APHP, University Paris Diderot, INSERM U942, Paris, France
  • ,
  • Isabelle Denjoy, MD

      Affiliations

    • Lariboisière Hospital APHP, University Paris Diderot, INSERM U942, Paris, France
  • ,
  • Antoine Leenhardt, MD

      Affiliations

    • Lariboisière Hospital APHP, University Paris Diderot, INSERM U942, Paris, France

Received 27 April 2010

Abstract 

Background

Spontaneous type 1 electrocardiographic (ECG) is a risk factor for arrhythmic events in Brugada patients but the importance of the proportion of time with a type 1 ECG is unknown.

Patients and Methods

Thirty-four Brugada patients (15 symptomatic) underwent a 24-hour 12-lead ECG recording. One-minute averaged waveforms displaying ST-segment elevation above 200 μV, with descending ST-segment and negative T-wave polarity on leads V1-V3 were considered as type 1 Brugada ECG. The burden was defined as the percentage of type 1 Brugada waveforms.

Results

Type 1 ECG on lead V2 was more frequent in symptomatic patients (median 80.6% [15.7–96.7] vs 12.4% [0.0–69.7], P = .05). Patients with a permanent type 1 pattern on lead V2 were more likely to be symptomatic (5/6) than patients without type 1 ECG during a 24-hour period (2/9) (P < .05).

Conclusion

Type 1 pattern is more prevalent across a 24-hour period in symptomatic Brugada patients.

Keywords: Brugada syndrome, Holter ECG

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Disclosure: Fabio Badilini is vice president of AMPS LLC, the company that developed the software for the ELA Sorin Group. Other authors have no conflicts of interest and received no financial support.

PII: S0022-0736(10)00275-X

doi:10.1016/j.jelectrocard.2010.06.011

Journal of Electrocardiology
Volume 43, Issue 5 , Pages 408-414, September 2010